Skip to main content
Clinical Trials/NCT03543397
NCT03543397UnknownNot Applicable

Relevance of Mammary MRI in the Preoperative Assessment of Ductal Carcinoma in Situ (DCIS)

University Hospital, Strasbourg, France1 site in 1 country74 target enrollmentStarted: February 26, 2018Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Sponsor
Enrollment
74
Locations
1
Primary Endpoint
The investigators compare the estimate of the lesional size in MRI to that in mammography, taking as a reference the definitive anatomo-pathological size

Study Overview

Brief Summary

Compare the estimate of the lesional size in MRI to that in mammography, taking as a reference the definitive anatomo-pathological size

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Retrospective

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
Female
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Age ≥18 ans
  • Woman with DCIS

Exclusion Criteria

  • Age ≥18 ans)

Outcomes

Primary Outcomes

The investigators compare the estimate of the lesional size in MRI to that in mammography, taking as a reference the definitive anatomo-pathological size

Time Frame: The period from January 1st, 2017 to December 31st, 2017 will be examined]

Patients hospitalized at Strasbourg University Hospital in 2017

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
University Hospital, Strasbourg, France
Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials